Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALABettina E. Hansen, Douglas Mogul, Kathleen M. Loomes et al.|Hepatology|2023Cited by 33
Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver diseaseJake P. Mann, Ulli Baumann, Anita Vreugdenhil et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 27
OC7 Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients with from the GALA database: application of real-world evidence analyticsBE Hansen, SM Vandriel, Pamela Vig et al.|Abstracts|2023Cited by 0